HRT Financial’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.3M Buy
+137,982
New +$20.2M 0.04% 397
2025
Q4
– Sell
-103,593
Closed -$9.84M – 3564
2025
Q3
$9.84M Sell
103,593
-59,977
-37% -$5.95M 0.04% 404
2025
Q2
$15.6M Buy
+163,570
New +$13.3M 0.07% 202
2025
Q1
– Sell
-377,586
Closed -$50.5M – 2918
2024
Q4
$50.5M Buy
377,586
+372,735
+7,684% +$53.1M 0.26% 52
2024
Q3
$632K Sell
4,851
-75,320
-94% -$9.29M ﹤0.01% 1478
2024
Q2
$8.37M Buy
+80,171
New +$8.99M 0.05% 279
2022
Q3
– Sell
-18,257
Closed -$3.61M – 3131
2022
Q2
$3.27M Buy
+18,257
New +$4.66M 0.04% 385
2021
Q4
– Sell
-21,126
Closed -$8M – 3595
2021
Q3
$8.34M Buy
+21,126
New +$9.72M 0.05% 192
2021
Q2
– Sell
-2,903
Closed -$1.08M – 3153
2021
Q1
$1.08M Buy
+2,903
New +$1.18M 0.01% 1043
2018
Q3
– Sell
-980
Closed -$266K – 448
2018
Q2
$266K Buy
+980
New +$249K 0.1% 163
2015
Q4
– Sell
-1,943
Closed -$332K – 89
2015
Q3
$332K Buy
+1,943
New +$393K 0.28% 50

Other funds holding ILMN

HRT Financial's ILMN Position: Q2 2026 in Review

HRT Financial opened a new position in Illumina (ILMN) in Q2 2026: 137,982 shares worth $24.3M. The stake represents 0.04% of the portfolio and ranks #397 among its holdings. This is a return to the name: HRT Financial previously reported a position in ILMN as recently as Q3 2025.

HRT Financial first reported a position in ILMN in Q3 2015 and has held it in 11 quarters since. The position peaked at $50.5M in Q4 2024. 939 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • HRT Financial held 137,982 shares of Illumina worth $24.3M as of Q2 2026.
  • Illumina was a new HRT Financial position in Q2 2026.
  • Illumina made up 0.04% of HRT Financial's portfolio in Q2 2026, its #397 holding.
  • HRT Financial first reported a position in Illumina in Q3 2015 and has held it in 11 quarters since.
  • HRT Financial's Illumina position peaked at $50.5M in Q4 2024.
  • 939 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.